Clinic
Williamson and Associates, Family Health Care LLC
Williamson and Associates, Family Health Care LLC was paid $446K by Medicaid between Apr 2020 and Nov 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoWILLIAMSON AND ASSOCIATES, FAMILY HEALTH CARE LLC
CHILLICOTHE, OH 45601
CHILLICOTHE, OH 45601
33aNPI1629609292assigned 01/31/2020
33bProvider typePrimary Care Clinic/Center
28Total paid$446K
24GClaims19,993
24DCodes billed54
24AFirst – last monthApr 2020 – Nov 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Ohio
Rank by total paid#20 of 118
Median peer was paid$67K
This provider vs. median6.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 4,351 | $101K | |
| 2021 | 7,092 | $136K | |
| 2022 | 4,509 | $101K | |
| 2023 | 3,304 | $85K | |
| 2024incomplete | 737 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 2,700 | 2,074 | $128K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 2,134 | 1,768 | $69K |
| 99401 | 11% | 2,329 | 1,736 | $47K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 8.3% | 515 | 451 | $37K |
| 99205 | Prolong outpt/office vis | 5.0% | 307 | 235 | $22K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.8% | 1,084 | 896 | $21K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 331 | 286 | $15K |
| 99402 | 2.4% | 422 | 365 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 688 | 492 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 560 | 477 | $10K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.9% | 214 | 194 | $8K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.8% | 203 | 177 | $8K |
42 more codes
| A4927 | Gloves, non-sterile, per 100 | 1.5% | 1,043 | $7K |
| 86769 | 1.5% | 218 | $7K | |
| 86328 | 1.4% | 199 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 510 | $5K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 2,635 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 78 | $4K |
| 92558 | <1% | 256 | $4K | |
| 96127 | <1% | 732 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 63 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 71 | $2K |
| 99406 | <1% | 270 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 82 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 31 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 94 | $1K |
| 87634 | <1% | 28 | $1K | |
| 36416 | <1% | 286 | $960.25 | |
| 87807 | <1% | 106 | $860.56 | |
| 99385 | <1% | 24 | $736.80 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 28 | $661.14 |
| 90686 | <1% | 29 | $434.23 | |
| 87077 | <1% | 130 | $388.98 | |
| 86580 | <1% | 71 | $362.10 | |
| 81003 | <1% | 204 | $257.30 | |
| 96161 | <1% | 110 | $237.51 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15 | $186.28 |
| 85018 | <1% | 130 | $177.84 | |
| 92551 | <1% | 25 | $152.00 | |
| 81002 | <1% | 67 | $134.54 | |
| 82947 | <1% | 71 | $123.09 | |
| 90688 | <1% | 13 | $122.88 | |
| 99173 | <1% | 28 | $57.60 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 34 | $36.74 |
| 87070 | <1% | 20 | $19.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $14.74 |
| 94760 | <1% | 267 | $0.87 | |
| 91300 | <1% | 31 | $0.29 | |
| 99072 | 0% | 96 | $0.00 | |
| 99001 | 0% | 76 | $0.00 | |
| 98960 | 0% | 38 | $0.00 | |
| 99071 | 0% | 28 | $0.00 | |
| 99070 | 0% | 245 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMSON, REGINA (OWNER/ NP)